StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research report report published on Monday morning. The firm issued a hold rating on the software maker’s stock.
Separately, Stephens increased their price target on Veradigm from $7.00 to $13.00 and gave the company an “equal weight” rating in a report on Friday, January 31st.
Get Our Latest Report on Veradigm
Veradigm Price Performance
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Further Reading
- Five stocks we like better than Veradigm
- Best Stocks Under $10.00
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- The Role Economic Reports Play in a Successful Investment Strategy
- Alphabet’s Officially In A Bear Market—Time To Buy?
- Consumer Discretionary Stocks Explained
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
